BioRestorative Therapies, Inc. - Common Stock (BRTX)
0.2848
+0.0528 (22.76%)
NASDAQ · Last Trade: Mar 10th, 6:46 PM EDT
Detailed Quote
Previous Close
0.2320
Open
0.3020
Bid
0.2656
Ask
0.2662
Day's Range
0.2515 - 0.3033
52 Week Range
0.1900 - 2.100
Volume
159,458,754
Market Cap
2.53M
PE Ratio (TTM)
-0.1937
EPS (TTM)
-1.5
Dividend & Yield
N/A (N/A)
1 Month Average Volume
17,518,839
Chart
About BioRestorative Therapies, Inc. - Common Stock (BRTX)
Biorestorative Therapies Inc is a biotechnology company focused on developing innovative solutions for regenerative medicine, particularly in the areas of musculoskeletal and metabolic diseases. The company is engaged in researching and commercializing therapeutic products using advanced cellular technologies, including adult stem cells. Biorestorative Therapies aims to create treatments that enhance the body's natural healing processes, with a commitment to addressing unmet medical needs and improving patient outcomes through its proprietary methods and therapies. Read More
Full Alliance Group, Inc. (OTC: FAGI) is emerging as a diversified microcap company executing a multi-division strategy that combines operating businesses with next-generation digital infrastructure initiatives.
